Figure 1 - The antiviral market.

From the following article

Antivirals—an increasingly healthy investment

Brian McCarthy

Nature Biotechnology 25, 1390 - 1393 (2007)

doi:10.1038/nbt1207-1390

BACK TO ARTICLE
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

The antiviral market is currently valued near $18 billion, with the largest submarkets comprising drugs for the treatment of HIV and the hepatitis viruses. Dollar amounts are in billions.

Figures and tables index
BACK TO ARTICLE